M&A

A bidding war is brewing over $50 billion drugmaker Shire
Business Insider
Thu, 04/19/18 - 10:17 am
Shire
Takeda
Allergan
M&A
Takeda makes $61 billion bid for drugmaker Shire: sources
Reuters
Thu, 04/19/18 - 09:19 am
Takeda
Shire
M&A
Shire's oncology exit weighs on potential Takeda bid
Biopharma Dive
Tue, 04/17/18 - 09:37 am
Shire
oncology
Takeda
M&A
Servier
[video]Did Novartis Overpay for AveXis?
Motley Fool
Mon, 04/16/18 - 11:34 pm
Novartis
AveXis
gene therapy
M&A
Boston Scientific acquires NVision Medical in $275m deal
Mass Device
Mon, 04/16/18 - 10:33 am
Boston Scientific
NVision Medical
M&A
devices
diagnostics
ovarian cancer
Advent Is Said to Near Deal to Acquire Sanofi Generics Unit
Bloomberg
Mon, 04/16/18 - 09:28 am
Advent International
Sanofi
generics
M&A
Servier buys Shire’s oncology unit for $2.4B in the run-up to Takeda’s final buyout offer — if it makes one
Endpoints
Mon, 04/16/18 - 09:12 am
Servier
Shire
Takeda
M&A
oncology
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 04/14/18 - 12:37 pm
AveXis
Abeona Therapeutics
Spectrum Pharmaceuticals
Novartis
M&A
poziotinib
EB-101
Merck KGaA Consumer Unit Is a Deal Too Far for Mylan: Gadfly
Washington Post, DC
Sat, 04/14/18 - 12:34 pm
Merck KGaA
consumer health
M&A
Mylan Labs
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Bloomberg
Fri, 04/13/18 - 08:52 am
Pfizer
M&A
Bristol-Myers Squibb
Celgene
Eli Lilly
AstraZeneca
Mylan seeks deal for German Merck's consumer products unit - sources
Yahoo/Reuters
Fri, 04/13/18 - 08:49 am
Mylan Labs
Merck KGaA
consumer health
M&A
Trust me, Pfizer isn't interested in buying BMS, analyst says—at least not yet
Fierce Pharma
Thu, 04/12/18 - 11:54 am
Pfizer
M&A
Ian Read
Bristol-Myers Squibb
Alexion buying Swedish biotech for $855 million to broaden rare disease pipeline
Stat
Wed, 04/11/18 - 11:10 am
Alexion
WIlson Therapeutics
M&A
Rare Diseases
Teva's M&A-gone-wrong lawsuit over Rimsa deal nets a paltry settlement
Fierce Pharma
Wed, 04/11/18 - 09:49 am
Teva Pharmaceutical
generics
fraud
Rimsa
M&A
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'
Forbes
Mon, 04/9/18 - 03:31 pm
Novartis
Vas Narasimhan
M&A
gene therapy
AveXis
Celgene on biotech hunt with Agios, Jounce in crosshairs: FT
Fierce Biotech
Mon, 04/9/18 - 10:33 am
Celgene
M&A
Agios Pharmaceuticals
Jounce Therapeutics
Biogen faces increased 'pressure' after AveXis buyout by Novartis
Marketwatch
Mon, 04/9/18 - 09:10 am
Novartis
AveXis
Biogen
SMA
M&A
AVXS-1-1
Spinraza
Novartis buying AveXis for $8.7 billion to strengthen gene therapy capabilities
Stat
Mon, 04/9/18 - 09:00 am
Novartis
M&A
AveXis
gene therapy
AVXS-101
SMA
spinal muscular atrophy
Major restructuring with staff cuts in US for Teva
GoinPharma
Sun, 04/8/18 - 12:19 pm
Teva Pharmaceutical
M&A
restructuring
AssistRx
Parkinson's Disease
multiple sclerois
[video]Will Shire Be Bought Out?
Motley Fool
Sun, 04/8/18 - 12:12 pm
Shire
M&A
Takeda

Pages